McLeod Encourages Life-Saving
Lung Cancer Screening

Lung Cancer ranks as the leading cause of cancer-related deaths in the U.S., taking more lives than breast, prostate and colorectal cancers combined. Thanks to a National Lung Cancer Screening Trial, heavy smokers can significantly reduce their chances of lung cancer with a low-dose CT Scan over a 3-year period. McLeod urges past and current smokers to take advantage of this special program.

The American College of Radiology has designated McLeod Regional Medical Center, McLeod Health Dillon, McLeod Health Cheraw, McLeod Health Clarendon, and McLeod Health Seacoast as Lung Cancer Screening Centers. The ACR Lung Cancer Screening Center designation is a voluntary program that recognizes facilities that have committed to practice safe, effective diagnostic care for individuals at the highest risk for lung cancer. McLeod Health has also received designation as a Care Continuum Center of Excellence by the GO2 Foundation for Lung Cancer. The designation recognizes a commitment to improving outcomes for those diagnosed with lung cancer by providing patient-focused and coordinated multidisciplinary care. The GO2Foundation formed the Care Continuum Centers of Excellence program to enable patient access to standard of care lung cancer screening, early detection, diagnosis, treatment and survivorship in their local community.

For information on the lung cancer screening program, please call (843) 777-5953 or if you live in the North Myrtle Beach area, call (843) 366-2220.

If you are a healthcare provider and would like to schedule your patient for a lung cancer screening:

Click here to download Order Form

  • National Task Force Urges Lung Cancer Screenings for Heavy Smokers

    In 2013, the United States Preventive Services Task Force recommended lung cancer screenings for adults who:

    • Are between 50 to 80 years of age and have had a 20 or more pack-year history of cigarette smoking (20 pack-year is equivalent to one pack per day for 20 years or two packs per day for 10 years)
    • Do not currently exhibit any symptoms of lung cancer
    • Have quit smoking within the last 15 years
    • Are interested in being screened for lung cancer
  • Benefits of the McLeod Lung Cancer Screening Program Involve:

    • Low-dose CT scan,
    • Professional interpretation by McLeod Radiologist who will either recommend a one-year follow-up or further testing,
    • Free smoking-cessation counseling,
    • Results sent to your primary care physician

    Talk with your primary care physician if you’re interested in scheduling a Lung Cancer Screening.

  • Qualified Individuals Offered Lung Cancer Screening Scholarships to Cover Cost

    Medicare and most private insurances cover the cost of the Low-Dose CT scan if you meet the criteria for a lung cancer screening. Ages covered by Medicare are 55 to 77; private insurance will pay for those 55 to 80. Lung Cancer Screening Scholarships, funded by the McLeod Foundation’s McLeod Men’s group and McLeod Angels, are available for those who are uninsured and/or unable to pay for a Low-Dose CT Screening. For information on the lung cancer screening program, please call (843) 777-5953 or if you live in the North Myrtle Beach area, call (843) 366-2220.


  • Low Dose CT Scan Only One of Many Lung Cancer Diagnostic, Treatment Tools

    Special ultrasounds for the throat and chest area, as well as stents and argon laser treatments, are new tools McLeod Center for Cancer Treatment and Research uses for lung cancer patients. Other technology lung cancer patients benefit from include PET/CT scan, Stereotactic Body Radiation Therapy (SBRT) and molecular targeted therapy.

  • LungGPS Enables McLeod to Detect Incidental Lung Nodules

    A key goal of the McLeod Healthy Lungs Initiative (HLI) is to shift the prevailing trend of diagnosing lung cancer at late stages to early-stage discovery. In so doing, our teams will be able to successfully treat and cure more lung cancers. With the help of a grant from The McLeod Health Foundation, LungGPS software was purchased to give us the capability to identify patients who have incidental lung nodules across all McLeod Health facilities.

    READ More